


Gain Therapeutics
Biotechnology Research • Bethesda, Maryland, United States • 21-50 Employees
Company overview
| Headquarters | 4800 Montgomery Ln, Suite 220, Bethesda, Maryland 20814, US |
| Phone number | +13015001556 |
| Website | |
| NAICS | 541714 |
| Keywords | Oncology, Rare Diseases, Neurodegenerative Diseases, Pharmacological Chaperones, Lysosomal Storage Disorders |
| Founded | 2017 |
| Employees | 21-50 |
| Socials |
Key Contacts at Gain Therapeutics
Gwen Melincoff
Member Board Of Directors
Gene Mack
Chief Executive Officer
Rinaldo Wander Montalvão
Director Of Artificial Intelligence
Roshan Ahmed
Senior Director, Business Development
Alberto Bretoni
Finance Director
Gain Therapeutics Email Formats
Gain Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@gaintherapeutics.com), used 52.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@gaintherapeutics.com | 52.2% |
{first initial}{last name} | jdoe@gaintherapeutics.com | 47.8% |
About Gain Therapeutics
Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate, GT-02287 is currently being evaluated for the treatment of Parkinson’s disease with or without a GBA1 mutation. Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma exposure in the projected therapeutic range, CNS exposure, and target engagement and modulation of GCase enzyme. Gain’s unique approach enables the discovery of novel, allosteric small molecule modulators that can restore or disrupt protein function. Deploying its highly advanced Magellan™ platform, Gain is accelerating drug discovery and unlocking novel disease-modifying treatments for untreatable or difficult-to-treat disorders including neurodegenerative diseases, rare genetic disorders and oncology.
Gain Therapeutics revenue & valuation
| Annual revenue | $55,180 |
| Revenue per employee | $2,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $176,576 |
| Total funding | $17,100,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Gain Therapeutics has 13 employees across 9 departments.
Departments
Number of employees
Funding Data
Explore Gain Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Gain Therapeutics Tech Stack
Discover the technologies and tools that power Gain Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CMS
Security
Caching
Cookie compliance
UI frameworks
Page builders
CDN
SEO
Miscellaneous
Programming languages
Blogs
Frequently asked questions
4.8
40,000 users



